Skip to main content
NCBI home page
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1999;26(1):60–70.

Heart transplantation: approaching a new century.

B Radovancević 1, O H Frazier 1
PMCID: PMC325599  PMID: 10217471

Abstract

Although cardiac surgeons have gained considerable experience with heart transplantation during the past 30 years, this operation still presents many challenges. The number of transplant candidates continues to exceed the number of available donor hearts, and the shortage is not expected to improve. For patients fortunate enough to receive a donor heart, perioperative mortality is a serious concern. After the 1st postoperative year, the most frequent cause of death is transplant vasculopathy. Other potential complications include renal dysfunction, bleeding, infection, and allograft rejection. Despite these problems, heart transplantation remains the best hope for patients with end-stage heart failure that is unresponsive to conventional therapy. In the future, mechanical cardiac assistance and new medical treatments for end-stage heart disease may offer alternatives to heart transplantation, reducing the competition for scarce donor hearts.

Full text

PDF
60

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreone P. A., Olivari M. T., Elick B., Arentzen C. E., Sibley R. K., Bolman R. M., Simmons R. L., Ring W. S. Reduction of infectious complications following heart transplantation with triple-drug immunotherapy. J Heart Transplant. 1986 Jan-Feb;5(1):13–19. [PubMed] [Google Scholar]
  2. Armitage J. M., Kormos R. L., Fung J., Starzl T. E. The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. Transplant Proc. 1991 Dec;23(6):3054–3057. [PMC free article] [PubMed] [Google Scholar]
  3. Auler Júnior J. O., Carmona M. J., Bocchi E. A., Bacal F., Fiorelli A. I., Stolf N. A., Jatene A. D. Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant. 1996 May;15(5):443–450. [PubMed] [Google Scholar]
  4. Baldwin R. T., Radovancevic B., Sweeney M. S., Duncan J. M., Frazier O. H. Bacterial mediastinitis after heart transplantation. J Heart Lung Transplant. 1992 May-Jun;11(3 Pt 1):545–549. [PubMed] [Google Scholar]
  5. Barnard C. N., Losman J. G. Left ventricular bypass. S Afr Med J. 1975 Mar 1;49(9):303–312. [PubMed] [Google Scholar]
  6. Barr M. L., Meiser B. M., Eisen H. J., Roberts R. F., Livi U., Dall'Amico R., Dorent R., Rogers J. G., Radovancević B., Taylor D. O. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med. 1998 Dec 10;339(24):1744–1751. doi: 10.1056/NEJM199812103392404. [DOI] [PubMed] [Google Scholar]
  7. Benedict C. R., Weiner D. H., Johnstone D. E., Bourassa M. G., Ghali J. K., Nicklas J., Kirlin P., Greenberg B., Quinones M. A., Yusuf S. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):146A–153A. doi: 10.1016/0735-1097(93)90480-o. [DOI] [PubMed] [Google Scholar]
  8. Billingham M. E., Cary N. R., Hammond M. E., Kemnitz J., Marboe C., McCallister H. A., Snovar D. C., Winters G. L., Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990 Nov-Dec;9(6):587–593. [PubMed] [Google Scholar]
  9. Bramwell N. H., Davies R. A., Koshal A., Tse G. N., Keon W. J., Walley V. M. Fatal gastrointestinal hemorrhage caused by cytomegalovirus duodenitis and ulceration after heart transplantation. J Heart Transplant. 1987 Sep-Oct;6(5):303–306. [PubMed] [Google Scholar]
  10. Bristow M. R., O'Connell J. B., Gilbert E. M., French W. J., Leatherman G., Kantrowitz N. E., Orie J., Smucker M. L., Marshall G., Kelly P. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. Circulation. 1994 Apr;89(4):1632–1642. doi: 10.1161/01.cir.89.4.1632. [DOI] [PubMed] [Google Scholar]
  11. Chou S. W., Norman D. J. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients. Transplantation. 1988 Jul;46(1):89–93. doi: 10.1097/00007890-198807000-00016. [DOI] [PubMed] [Google Scholar]
  12. Cooley D. A., Frazier O. H., Kadipasaoglu K. A., Pehlivanoglu S., Shannon R. L., Angelini P. Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. Tex Heart Inst J. 1994;21(3):220–224. [PMC free article] [PubMed] [Google Scholar]
  13. Costanzo-Nordin M. R., Hubbell E. A., O'Sullivan E. J., Johnson M. R., Mullen G. M., Heroux A. L., Kao W. G., McManus B. M., Pifarre R., Robinson J. A. Successful treatment of heart transplant rejection with photopheresis. Transplantation. 1992 Apr;53(4):808–815. doi: 10.1097/00007890-199204000-00021. [DOI] [PubMed] [Google Scholar]
  14. Costanzo M. R., Naftel D. C., Pritzker M. R., Heilman J. K., 3rd, Boehmer J. P., Brozena S. C., Dec G. W., Ventura H. O., Kirklin J. K., Bourge R. C. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant. 1998 Aug;17(8):744–753. [PubMed] [Google Scholar]
  15. Dibner-Dunlap M. E., Thames M. D. A simplified technique for the production of heart failure in the dog by rapid ventricular pacing. Am J Med Sci. 1990 Nov;300(5):288–290. doi: 10.1097/00000441-199011000-00003. [DOI] [PubMed] [Google Scholar]
  16. Dreyfus G., Jebara V., Mihaileanu S., Carpentier A. F. Total orthotopic heart transplantation: an alternative to the standard technique. Ann Thorac Surg. 1991 Nov;52(5):1181–1184. doi: 10.1016/0003-4975(91)91311-i. [DOI] [PubMed] [Google Scholar]
  17. Evans M. A., Schomberg P. J., Rodeheffer R. J., Katzmann J. A., Schnell W. A., Jr, Tazelaar H. D., McGregor C. G., Edwards B. S. Total lymphoid irradiation: a novel and successful therapy for resistant cardiac allograft rejection. Mayo Clin Proc. 1992 Aug;67(8):785–790. doi: 10.1016/s0025-6196(12)60804-0. [DOI] [PubMed] [Google Scholar]
  18. Frazier O. H., Kadipasaoglu K. A., Radovancevic B., Cihan H. B., March R. J., Mirhoseini M., Cooley D. A. Transmyocardial laser revascularization in allograft coronary artery disease. Ann Thorac Surg. 1998 Apr;65(4):1138–1141. doi: 10.1016/s0003-4975(98)00022-8. [DOI] [PubMed] [Google Scholar]
  19. Frazier O. H., Rose E. A., Macmanus Q., Burton N. A., Lefrak E. A., Poirier V. L., Dasse K. A. Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg. 1992 Jun;53(6):1080–1090. doi: 10.1016/0003-4975(92)90393-i. [DOI] [PubMed] [Google Scholar]
  20. Gangahar D. M., Liggett S. P., Casey J., Carveth S. W., Reese H. E., Buchman R. J., Breiner M. A. Two episodes of cytomegalovirus-associated colon perforation after heart transplantation with successful result. J Heart Transplant. 1988 Sep-Oct;7(5):377–379. [PubMed] [Google Scholar]
  21. Hosenpud J. D., Bennett L. E., Keck B. M., Fiol B., Boucek M. M., Novick R. J. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report--1998. J Heart Lung Transplant. 1998 Jul;17(7):656–668. [PubMed] [Google Scholar]
  22. Hunt S. A., Strober S., Hoppe R. T., Stinson E. B. Total lymphoid irradiation for treatment of intractable cardiac allograft rejection. J Heart Lung Transplant. 1991 Mar-Apr;10(2):211–216. [PubMed] [Google Scholar]
  23. Jeevanandam V., Mather P., Furukawa S., Todd B., Regillo T., Bove A. A., McClurken J., Addonizio V. P. Adult orthotopic heart transplantation using undersized pediatric donor hearts. Technique and postoperative management. Circulation. 1994 Nov;90(5 Pt 2):II74–II77. [PubMed] [Google Scholar]
  24. Jeevanandam V., Todd B., Regillo T., Hellman S., Eldridge C., McClurken J. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant. 1994 Jul-Aug;13(4):681–687. [PubMed] [Google Scholar]
  25. Kaplan C. S., Petersen E. A., Icenogle T. B., Copeland J. G., Villar H. V., Sampliner R., Minnich L., Ray C. G. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients. Arch Intern Med. 1989 Sep;149(9):2095–2100. [PubMed] [Google Scholar]
  26. Kirklin J. K., Bourge R. C., Naftel D. C., Morrow W. R., Deierhoi M. H., Kauffman R. S., White-Williams C., Nomberg R. I., Holman W. L., Smith D. C., Jr Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience. J Heart Lung Transplant. 1994 May-Jun;13(3):444–450. [PubMed] [Google Scholar]
  27. Kobashigawa J. A., Katznelson S., Laks H., Johnson J. A., Yeatman L., Wang X. M., Chia D., Terasaki P. I., Sabad A., Cogert G. A. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995 Sep 7;333(10):621–627. doi: 10.1056/NEJM199509073331003. [DOI] [PubMed] [Google Scholar]
  28. Kobashigawa J., Miller L., Renlund D., Mentzer R., Alderman E., Bourge R., Costanzo M., Eisen H., Dureau G., Ratkovec R. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation. 1998 Aug 27;66(4):507–515. doi: 10.1097/00007890-199808270-00016. [DOI] [PubMed] [Google Scholar]
  29. LOCKETT M. F. DANGEROUS EFFECTS OF ISOPRENALINE IN MYOCARDIAL FAILURE. Lancet. 1965 Jul 17;2(7403):104–106. doi: 10.1016/s0140-6736(65)92221-x. [DOI] [PubMed] [Google Scholar]
  30. LOWER R. R., SHUMWAY N. E. Studies on orthotopic homotransplantation of the canine heart. Surg Forum. 1960;11:18–19. [PubMed] [Google Scholar]
  31. Lake K. D., Smith C. I., LaForest S. K., Allen J., Pritzker M. R., Emery R. W. Policies regarding the transplantation of hepatitis C-positive candidates and donor organs. J Heart Lung Transplant. 1997 Sep;16(9):917–921. [PubMed] [Google Scholar]
  32. Laks H., Scholl F. G., Drinkwater D. C., Blitz A., Hamilton M., Moriguchi J., Fonarow G., Kobashigawa J. The alternate recipient list for heart transplantation: does it work? J Heart Lung Transplant. 1997 Jul;16(7):735–742. [PubMed] [Google Scholar]
  33. Maeda K., Taniwaki K., Santo T., Itsukuma T., Ito M., Anan K., Misawa M., Ohe Y., Kai S., Hara H. Anti-A and/or anti-B is not detectable in some patients who underwent ABO-incompatible bone marrow transplantation. Transfusion. 1995 Aug;35(8):635–639. doi: 10.1046/j.1537-2995.1995.35895357893.x. [DOI] [PubMed] [Google Scholar]
  34. Mancini D. M., Eisen H., Kussmaul W., Mull R., Edmunds L. H., Jr, Wilson J. R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991 Mar;83(3):778–786. doi: 10.1161/01.cir.83.3.778. [DOI] [PubMed] [Google Scholar]
  35. McAllister H. A., Jr, Schnee M. J., Radovancević B., Frazier O. H. A system for grading cardiac allograft rejection. Tex Heart Inst J. 1986 Mar;13(1):1–3. [PMC free article] [PubMed] [Google Scholar]
  36. Nakatani T., Frazier O. H., Lammermeier D. E., Macris M. P., Radovancevic B. Heterotopic heart transplantation: a reliable option for a select group of high-risk patients. J Heart Transplant. 1989 Jan-Feb;8(1):40–47. [PubMed] [Google Scholar]
  37. Nakatani T., Radovancevic B., Frazier O. H. Right heart assist for acute right ventricular failure after orthotopic heart transplantation. ASAIO Trans. 1987 Jul-Sep;33(3):695–698. [PubMed] [Google Scholar]
  38. Novitzky D., Cooper D. K., Barnard C. N. The surgical technique of heterotopic heart transplantation. Ann Thorac Surg. 1983 Oct;36(4):476–482. doi: 10.1016/s0003-4975(10)60492-4. [DOI] [PubMed] [Google Scholar]
  39. Patel V. S., Radovancevic B., Springer W., Frazier O. H., Massin E., Benrey J., Kadipasaoglu K., Cooley D. A. Revascularization procedures in patients with transplant coronary artery disease. Eur J Cardiothorac Surg. 1997 May;11(5):895–901. doi: 10.1016/s1010-7940(97)01167-6. [DOI] [PubMed] [Google Scholar]
  40. Pollard R. B., Rand K. H., Arvin A. M., Merigan T. C. Cell-mediated immunity of cytomegalovirus infection in normal subjects and cardiac transplant patients. J Infect Dis. 1978 May;137(5):541–549. doi: 10.1093/infdis/137.5.541. [DOI] [PubMed] [Google Scholar]
  41. Radovancevic B., Frazier O. H., Gentry L. O., Okereke O. U., Cooley D. A. Successful treatment of invasive aspergillosis in a heart transplant patient. Tex Heart Inst J. 1985 Sep;12(3):233–237. [PMC free article] [PubMed] [Google Scholar]
  42. Roth D., Colona J., Burke G. W., Ciancio G., Esquenazi V., Miller J. Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. Transplantation. 1998 Jan 27;65(2):248–252. doi: 10.1097/00007890-199801270-00018. [DOI] [PubMed] [Google Scholar]
  43. Royston D. Aprotinin therapy in heart and heart-lung transplantation. J Heart Lung Transplant. 1993 Jan-Feb;12(1 Pt 1):S19–S25. [PubMed] [Google Scholar]
  44. Rubin R. H., Tolkoff-Rubin N. E. Infection: the new problems. Transplant Proc. 1989 Feb;21(1 Pt 2):1440–1445. [PubMed] [Google Scholar]
  45. Salter M. M., Kirklin J. K., Bourge R. C., Naftel D. C., White-Williams C., Tarkka M., Waits E., Bucy R. P. Total lymphoid irradiation in the treatment of early or recurrent heart rejection. J Heart Lung Transplant. 1992 Sep-Oct;11(5):902–912. [PubMed] [Google Scholar]
  46. Shuster L. D., Cox G., Bhatia P., Miner P. B., Jr Gastric mucosal nodules due to cytomegalovirus infection. Dig Dis Sci. 1989 Jan;34(1):103–107. doi: 10.1007/BF01536162. [DOI] [PubMed] [Google Scholar]
  47. Shutze W. P., Kirklin J. K., Cummings O. W., Aldrete J. S. Cytomegalovirus hemorrhoiditis in cardiac allograft recipients. Transplantation. 1991 Apr;51(4):918–920. doi: 10.1097/00007890-199104000-00040. [DOI] [PubMed] [Google Scholar]
  48. Simmons R. L., Matas A. J., Rattazzi L. C., Balfour H. H., Jr, Howard J. R., Najarian J. S. Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery. 1977 Nov;82(5):537–546. [PubMed] [Google Scholar]
  49. Stevenson L. W., Steimle A. E., Fonarow G., Kermani M., Kermani D., Hamilton M. A., Moriguchi J. D., Walden J., Tillisch J. H., Drinkwater D. C. Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol. 1995 Jan;25(1):163–170. doi: 10.1016/0735-1097(94)00357-v. [DOI] [PubMed] [Google Scholar]
  50. Stevenson L. W. Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant. 1991 May-Jun;10(3):468–476. [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES